Published in Pediatr Nephrol on January 01, 1995
Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24
HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens (1992) 6.87
Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63
Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts. J Exp Med (1977) 3.48
Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36
Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation (1993) 3.13
Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation (1991) 2.32
Risk factors for chronic rejection in renal allograft recipients. Transplantation (1993) 1.90
Acquired immune tolerance to cadaveric renal allografts. A study of three patients treated with total lymphoid irradiation. N Engl J Med (1989) 1.29
Immunological monitoring of long-surviving renal transplant recipients. Surgery (1977) 1.25
Cell-mediated lympholysis studies in renal allograft recipients. Transplantation (1981) 1.25
Donor-type microchimerism associated with graft rejection eight years after liver transplantation. N Engl J Med (1994) 1.13
Passenger lymphocytes in human liver allografts and their potential role after transplantation. Transplantation (1993) 1.04
Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity. Transplantation (1993) 0.98
Selective reduction of donor-specific cytotoxic T lymphocyte precursors in patients with a well-functioning kidney allograft. Transplantation (1987) 0.95
Renal transplant patients monitored by the cell-mediated lympholysis assay. Evaluation of its clinical value. Transplantation (1989) 0.93
The use of cyclosporine in living-related renal transplantation. Donor-specific hyporesponsiveness and steroid withdrawal. Transplantation (1984) 0.88
Evidence for suppressor cells and reduced CML induction by the donor in transplant patients. Transplant Proc (1978) 0.87
Renal transplant patients treated with total lymphoid irradiation show specific unresponsiveness to donor antigens the mixed leukocyte reaction (MLR). J Immunol (1987) 0.86
Acquired donor-specific hyporesponsiveness in long-term kidney allograft recipients. Transplant Proc (1991) 0.86
Mechanisms of CML hyporesponsiveness in long-term renal allograft recipients. Hum Immunol (1985) 0.84
Specific tolerance in human kidney allograft recipients. Cell Immunol (1972) 0.84
Clinical and immunological studies of cadaveric renal transplant recipients given total-lymphoid irradiation and maintained on low-dose prednisone. Transplantation (1988) 0.81
Specific recipient-donor unresponsiveness mediated by a suppressor cell system in human kidney allograft tolerance. Transplantation (1982) 0.80
Suppressor cells inhibiting the generation of cytotoxic T lymphocytes in long-term human transplant recipients. Proc Clin Dial Transplant Forum (1979) 0.78
Improved long-term graft outcome in lung transplant recipients who have donor antigen-specific hyporeactivity. J Heart Lung Transplant (1994) 0.78
Evidence of donor-specific cellular suppressor activity in donor-specific cell-mediated lympholysis unresponsiveness in renal transplant patients. Transplantation (1987) 0.76
20 years or more of follow-up of living kidney donors. Lancet (1992) 3.88
Limiting financial disincentives in live organ donation: a rational solution to the kidney shortage. Am J Transplant (2006) 3.31
A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant (1993) 2.69
Pregnancy outcomes after kidney donation. Am J Transplant (2009) 2.66
Organ donation in three major American cities with large Latino and black populations. Transplantation (1988) 2.41
DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med (1991) 2.14
American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00
Transplantation of discordant xenografts: a review of progress. Immunol Today (1990) 2.00
Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89
Long-term health status and quality of life outcomes of lung transplant recipients. Chest (1995) 1.86
Staging of bronchiolitis obliterans syndrome using home spirometry. Chest (1999) 1.86
Increased incidence of malignancy during chronic renal failure. Lancet (1975) 1.79
Are wound complications after a kidney transplant more common with modern immunosuppression? Transplantation (2001) 1.73
Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65
Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation (1995) 1.65
Long-term follow-up of living kidney donors: quality of life after donation. Transplantation (1999) 1.65
Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant (2010) 1.65
Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes (1989) 1.64
Complications and risks of living donor nephrectomy. Transplantation (1997) 1.61
NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis (1993) 1.54
Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg (1997) 1.52
Colon perforation after renal transplantation: a single-institution review. Clin Transplant (1997) 1.47
Parainfluenza virus respiratory infection after bone marrow transplantation. N Engl J Med (1992) 1.47
Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host. Semin Respir Infect (1995) 1.46
Successful transplantation after conversion of a positive crossmatch to negative by dissociation of IgM antibody. Transplantation (1989) 1.46
Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery (1977) 1.45
The equitable allocation of deceased donor lungs for transplant in children in the United States. Am J Transplant (2013) 1.44
Selective retransplant after graft loss to nonadherence: success with a second chance. Am J Transplant (2009) 1.44
First things first: laying the ethical and factual groundwork for living kidney donor selection standards. Am J Transplant (2008) 1.40
Recurrence of desquamative interstitial pneumonia after lung transplantation. Am J Respir Crit Care Med (1997) 1.40
Uremic pericardial effusion. Treatment by catheter drainage and local nonabsorbable steroid administration. Nephron (1976) 1.39
Factors influencing the development of hypercholesterolemia after cardiac transplantation. Am J Cardiol (1992) 1.39
Moral leadership no excuse for invective. Am J Obstet Gynecol (2001) 1.38
Health-related quality of life in kidney donors from the last five decades: results from the RELIVE study. Am J Transplant (2013) 1.34
Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis. Ann Surg (1980) 1.34
Human islet autotransplantation following pancreatectomy. Transplant Proc (1979) 1.30
Pancreatic islet cell transplantation. Surg Clin North Am (1978) 1.28
An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group. Transplantation (1996) 1.27
Transplantation of pediatric donor kidneys to adult recipients. Is there a critical donor age? Ann Surg (1986) 1.26
Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors. Ann Surg (1976) 1.26
Kidney, pancreas and liver allocation and distribution in the United States. Am J Transplant (2012) 1.24
Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation (1991) 1.24
Short- and long-term outcomes of kidney transplants with multiple renal arteries. Ann Surg (1995) 1.21
OPTN/SRTR 2011 Annual Data Report: lung. Am J Transplant (2013) 1.20
Effect of initial slow graft function on renal allograft rejection and survival. Clin Transplant (1997) 1.19
Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades. Am J Transplant (2012) 1.19
Risk factors for slow graft function after kidney transplants: a multivariate analysis. Clin Transplant (2002) 1.18
Human islet transplantation: a preliminary report. Transplant Proc (1977) 1.18
Effect of preoperative pulmonary artery pressure on early survival after lung transplantation for idiopathic pulmonary fibrosis. J Heart Lung Transplant (2005) 1.17
Pediatric renal transplants--results with sequential immunosuppression. Transplantation (1992) 1.16
Inflammation lesions in kidney transplant biopsies: association with survival is due to the underlying diseases. Am J Transplant (2011) 1.16
Isolation and characterization of NK cell or NK/T cell-specific cDNA clones. J Mol Cell Immunol (1990) 1.14
The immunohistopathology of glomerular antigens. II. The glomerular basement membrane, actomyosin, and fibroblast surface antigens in normal, diseased, and transplanted human kidneys. Am J Pathol (1978) 1.14
Revisiting traditional risk factors for rejection and graft loss after kidney transplantation. Am J Transplant (2011) 1.14
Pseudorejection: factors mimicking rejection in renal allograft recipients. Ann Surg (1977) 1.13
Acute lung injury. Pathogenesis of intraalveolar fibrosis. J Clin Invest (1991) 1.13
Prolongation of cardiac xenograft survival by depletion of complement. Transplantation (1993) 1.13
ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant (2009) 1.13
Hepatocellular transplantation in acute liver failure. Surgery (1977) 1.12
A multigene family on human chromosome 12 encodes natural killer-cell lectins. Immunogenetics (1993) 1.12
Evolution of kidney, pancreas, and islet transplantation for patients with diabetes at the University of Minnesota. Am J Surg (1993) 1.12
Immunologic factors: the major risk for decreased long-term renal allograft survival. Transplantation (1999) 1.11
Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation. J Heart Lung Transplant (2006) 1.10
Aspergillus airway colonization and invasive disease after lung transplantation. Chest (1997) 1.09
Chronic antigenic stimulation, herpesvirus infection, and cancer in transplant recipients. Lancet (1975) 1.09
Post-transplant malignant lymphoma. Distinctive morphologic features related to its pathogenesis. Am J Med (1976) 1.08
Early and late airway complications after lung transplantation: incidence and management. Ann Thorac Surg (1997) 1.08
OPTN/SRTR 2012 Annual Data Report: lung. Am J Transplant (2014) 1.07
Short-term culture of adult pancreatic fragments for purification and transplantation of islets of Langerhans. Surgery (1976) 1.07
Monitoring progress after lung transplantation from home-patient adherence. J Med Eng Technol (1997) 1.06
Observations of glomerular epithelial cell structure in patients with type I diabetes mellitus. Kidney Int (1987) 1.06
Sequential therapy--a prospective randomized trial of MALG versus OKT3 for prophylactic immunosuppression in cadaver renal allograft recipients. Transplantation (1992) 1.05
Determination of reliability and validity in home monitoring data of pulmonary function tests following lung transplantation. Res Nurs Health (1997) 1.05
Hepatocellular transplantation for treatment of D-galactosamine-induced acute liver failure in rats. Transplant Proc (1979) 1.04
Recipient risk factors have an impact on technical failure and patient and graft survival rates in bladder-drained pancreas transplants. Transplantation (1994) 1.04
Renal transplantation in infants. Ann Surg (1990) 1.04
Sequential measurement of peripheral blood allogeneic microchimerism levels and association with pulmonary function. Transplantation (1996) 1.03
Use of cardioprotective medications in kidney transplant recipients. Am J Transplant (2009) 1.03
Economic impact of delayed graft function. Transplant Proc (1991) 1.02
The dispersed pancreas: transplantation without islet purification in totally pancreatectomized dogs. Diabetologia (1977) 1.01
Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation (1993) 1.01
Gas-generating systems in acute renal allograft rejection in the rat. Co-induction of heme oxygenase and nitric oxide synthase. Transplantation (1996) 1.01
OPTN/SRTR 2013 Annual Data Report: lung. Am J Transplant (2015) 1.01
Simultaneous pancreas and kidney transplants versus single kidney transplants and previous kidney transplants in uremic patients and single pancreas transplants in nonuremic diabetic patients: comparison of rejection, morbidity, and long-term outcome. Transplant Proc (1990) 1.00
Letter: Increased serum creatinine resulting from hyperglycemia, mimicking transplant rejection. Ann Intern Med (1975) 1.00
Laparoscopic drainage of lymphoceles after kidney transplantation: indications and limitations. Surgery (1995) 1.00
One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group. Transplantation (1996) 1.00
Transplantation of dispersed pancreatic islet tissue in humans: autografts and allografts. Diabetes (1980) 0.99
Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity. Transplantation (1993) 0.98
Autotransplantation of pancreatic fragments to the portal vein and spleen of totally pancreatectomized dogs: a comparative evaluation. Ann Surg (1978) 0.98
Predicting clinical outcome in the elderly renal transplant recipient. Kidney Int (2000) 0.98
Pregnancy after donor nephrectomy. Transplantation (1996) 0.97
Clostridium difficile colitis after kidney and kidney-pancreas transplantation. Clin Transplant (1999) 0.96
Donor scoring system for cadaveric renal transplantation. Am J Transplant (2001) 0.96
Does statin usage reduce the risk of corticosteroid-related osteonecrosis in renal transplant population? Orthop Clin North Am (2009) 0.96
Assessing elements of informed consent among living donors. Clin Transplant (2010) 0.96
Diagnosis and treatment of cytomegalovirus disease in transplant patients based on gastrointestinal tract manifestations. Arch Surg (1991) 0.96